![](/img/cover-not-exists.png)
Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study
Calabresi, Peter A, Kieseier, Bernd C, Arnold, Douglas L, Balcer, Laura J, Boyko, Alexey, Pelletier, Jean, Liu, Shifang, Zhu, Ying, Seddighzadeh, Ali, Hung, Serena, Deykin, AaronVolume:
13
Language:
english
Journal:
The Lancet Neurology
DOI:
10.1016/S1474-4422(14)70068-7
Date:
July, 2014
File:
PDF, 290 KB
english, 2014